Scoop has an Ethical Paywall
Scoop InfoPages
This InfoPage in unregistered, if this is your news page register Pictor Limited for InfoPages here.
Pictor Limited - Latest News [Page 1]
Pictor Announces Seroprevalence Study Using Novel SARS-CoV-2 Antibody Test To Assess Kiwis’ Antibody Levels
Thursday, 22 December 2022, 6:27 pm | Pictor Limited
Pictor , a global leader in immunodiagnostics, today announced an important research project – the Pictor Antibody Clinical Trial (PACT-19) – which aims to gain important information and insights into the COVID-19 immunity profile of New Zealanders. “Serologic ... More >>
Pictor Receives CE Mark For PictArray™ SARS-CoV-2 Antibody Test, Indicating Whether Patients Require COVID-19 Booster
Thursday, 23 June 2022, 6:44 am | Pictor Limited
Following a recent funding round raising $8.8 million, Auckland biotech company Pictor today announced it has received confirmation of CE registration for its PictArray™ SARS-CoV-2 IgG enzyme-linked immunosorbent assay (ELISA) antibody test as per In ... More >>
Biotech Firm Tackling COVID-19 & M. Bovis Announces Successful Development Of Rapid, Accurate Johne’s Disease Assay
Monday, 13 June 2022, 8:18 pm | Pictor Limited
Auckland-based biotechnology company Pictor Limited has been developing an accurate, affordable multiplexed diagnostic test for Mycobacterium avium paratuberculosis (MAP) – also known as Johne’s disease – that could save the New Zealand dairy industry ... More >>
Bolstered By Investment, Pictor Partners With Mobility Health To Offer PictArray™ Antibody Test
Thursday, 14 April 2022, 10:05 am | Pictor Limited
LOS ANGELES, California, USA — April 13, 2022 — Following a new investment of $6.1 million (NZD $8.8 million), biotech company Pictor today announced a partnership with U.S. laboratory service provider Mobility Health , launching a new antibody ... More >>
Pictor's Completes Successful US Clinical Trials For Unique COVID Antibody Testing
Tuesday, 11 January 2022, 6:12 pm | Pictor Limited
New Zealand diagnostic biotech company Pictor’s world-leading COVID-19 antibody testing regime has completed validation trials at two separate sites the United States. The Pictor test simultaneously detects the presence of both anti-Spike Antigen (SP) ... More >>
Pictor Ltd. Announces Start Of US Clinical Trials For SARS-CoV-2 Serology Test
Wednesday, 27 October 2021, 7:54 am | Pictor Limited
Auckland-based diagnostic biotech company Pictor has taken a major step forward in the development of its COVID-19 antibody test, announcing it has signed two US laboratories to conduct clinical trials in the US. Earlier this year, Pictor announced ... More >>
Pictor Ready To Roll Out Game-changing COVID Antibody Test In New Zealand
Thursday, 21 October 2021, 11:55 am | Pictor Limited
World-leading COVID-19 antibody test developed by Auckland diagnostic biotech company Pictor will be available for use in New Zealand before the end of November, the company has announced. The test could make New Zealand’s long-awaited easing of border ... More >>
Pictor And SCIENION Partner To Commercialise High-throughput SARS-CoV-2 Antibody Testing System
Wednesday, 29 September 2021, 10:24 am | Pictor Limited
Auckland-based diagnostic biotech company Pictor has entered into a strategic collaboration with SCIENION, a BICO company, to commercialise a high throughput SARS-CoV-2 antibody testing system. The two companies will incorporate SCIENION’s CL2 sciREADER system ... More >>
IVD medical expert joins Pictor leadership team
Thursday, 2 September 2021, 10:10 am | Pictor Limited
Auckland-based biotechnology company Pictor Limited has named US-based Tadd S. Lazarus, M.D. as its Consulting Chief Medical Officer. Dr Lazarus, who is based in San Diego, California and Austin, Texas, brings extensive experience as a Medical Director and ... More >>
Fast disease testing just a pinprick away
Friday, 29 May 2009, 10:21 am | Pictor Limited
A biotechnology company that started life in an Auckland garage has signed deals with partners in India and Europe, just four years after its founders began developing unique technology that can screen for a range of diseases from just a drop of blood. More >>
